Definium Therapeutics, Inc.

DFTX Healthcare Biotechnology

In the quarter to June 2026, EPS fell 188.0%, free cash flow fell 78.3% and total debt fell 11.5%, each against the same quarter a year earlier.

32.10 2.16 −6.30%
Market cap
$4.6B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
1,092.10 380.56 419.32 215.85
Total non-current assets
20.80 20.73 20.78 21.07
Total Assets
1,112.90 401.29 440.10 236.92
Total current liabilities
157.20 81.11 66.70 65.42
Total non-current liabilities
37.02 41.33 41.08 40.90
Total liabilities
194.22 122.44 107.77 106.32
Common Equity (Total)
918.68 278.85 332.33 130.60
Shareholders Equity (Total)
918.68 278.85 332.33 130.60
Total Debt
36.47 40.77 40.58 40.39

Show all line items

In millions of $ except per-share values · columns are period end dates